Solution structure of the major binding protein for the immunosuppressant FK506.

结合位点 生物化学 蛋白质结构 生物物理学 血浆蛋白结合
作者
Jonathan M. Moore,Debra A. Peattie,Matthew J. Fitzgibbon,John A. Thomson
出处
期刊:Nature [Nature Portfolio]
卷期号:351 (6323): 248-250 被引量:131
标识
DOI:10.1038/351248a0
摘要

THE major FK506 binding protein (FKBP, relative molecular mass ∼11,800; Mr 11.8K) and cyclophilin (Mr∼ 17K) belong to a class of proteins termed immunophilins1. Although unrelated at the amino-acid sequence level, they both possess peptidyl-prolyl cis-trans isomerase activities which are inhibited by immuno-suppressants that block signal transduction pathways leading to T-lymphocyte activation. FK506 and rapamycin strongly inhibit the peptidyl-prolyl cis-trans isomerase activity of FKBP, whereas cyclosporin A inhibits that of cyclophilin2–12. The significance of this enzyme activity and the role of the immunophilins in immunoregulation is unknown1,13. To understand better the func-tion of the immunophilins and their interaction with inhibitors, we are investigating the solution structures of FKBP and FKBP-inhibitor complexes by multidimensional NMR methods. Here we report the solution conformation of FKBP, as generated by NMR, distance geometry and molecular dynamics methods. The regular secondary structure of FKBP is composed mainly of β sheet (∼35%) with little helical structure (<10%). The hydrophobic core of the molecule, containing the buried side chains of six of the protein s nine aromatic amino acids, is enclosed by a five-stranded antiparallel β sheet on one side, a loop and a short helix at residues 51–56 and 57–65, and an aperiodic loop at residues 81–95. Examination of the structure suggests a possible site of interaction with FK506.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
糖淘淘发布了新的文献求助10
2秒前
爆米花应助吃猫的鱼采纳,获得10
2秒前
3秒前
3秒前
dsgfg发布了新的文献求助10
3秒前
无尘发布了新的文献求助10
3秒前
yunyun发布了新的文献求助20
3秒前
hqh发布了新的文献求助10
4秒前
喷火娃发布了新的文献求助10
4秒前
4秒前
lighting完成签到 ,获得积分10
4秒前
壮观的文龙完成签到 ,获得积分20
4秒前
祝好发布了新的文献求助10
5秒前
thhsun发布了新的文献求助10
6秒前
lin完成签到,获得积分10
7秒前
7秒前
文艺莹芝发布了新的文献求助10
7秒前
hh完成签到,获得积分10
8秒前
8秒前
9秒前
saturn发布了新的文献求助10
9秒前
莫提斯发布了新的文献求助10
9秒前
神勇如天完成签到,获得积分10
10秒前
月亮的月发布了新的文献求助10
10秒前
10秒前
852应助lanchong采纳,获得10
10秒前
从容万恶完成签到,获得积分10
11秒前
11秒前
思源应助zhongsir采纳,获得10
12秒前
欣欣发布了新的文献求助10
13秒前
13秒前
小智发布了新的文献求助10
14秒前
彭于晏应助磷酸瞳采纳,获得10
14秒前
脑洞疼应助hqh采纳,获得10
15秒前
小马甲应助周洋采纳,获得10
15秒前
lucky发布了新的文献求助10
15秒前
15秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Burger's Medicinal Chemistry, Drug Discovery and Development, Volumes 1 - 8, 8 Volume Set, 8th Edition 1800
Cronologia da história de Macau 1600
Netter collection Volume 9 Part I upper digestive tract及Part III Liver Biliary Pancreas 3rd 2024 的超高清PDF,大小约几百兆,不是几十兆版本的 1050
Current concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents 1000
Research Handbook on the Law of the Sea 1000
Contemporary Debates in Epistemology (3rd Edition) 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6169464
求助须知:如何正确求助?哪些是违规求助? 7996964
关于积分的说明 16633150
捐赠科研通 5274379
什么是DOI,文献DOI怎么找? 2813727
邀请新用户注册赠送积分活动 1793536
关于科研通互助平台的介绍 1659360